A federal judge has ruled that CVS' purchase of Aetna was legal under antitrust law; the Trump administration announced $1.8 billion in grants to help states and communities combat the opioid epidemic; Johns Hopkins Medicine has launched the first psychedelic research center in the United States.
A federal judge has approved CVS’ purchase of Aetna, agreeing with a Justice Department decision that the merger is legal under antitrust law, Reuters has reported. A government plan announced in October said it would allow the merger on the condition that the health insurer sell its Medicare prescription drug plan business to WellCare Health Plans. Both deals have already closed, and since then, Centene has agreed to acquire WellCare for $15.27 billion. CVS said the judge’s decision reinforced that CVS and Aetna have already merged.
The Trump administration on Wednesday announced that it is awarding $1.8 billion in grants to help combat the opioid epidemic. Approximately $980 million will go to states and some territories to focus on prevention and treatment, including through expanding rural telemedicine, expanding access to overdose reversal drug naloxone, and prevention programs. According to The Wall Street Journal, another $900 million will go to CDC over 3 years in order to help states and communities track overdose data and implement treatment strategies.
Johns Hopkins Medicine has launched the Center for Psychedelic and Consciousness Research, the first of its kind in the country. The center will study substances like LSD and psilocybin for a variety of mental health conditions, including anorexia, addiction, and depression, reported The New York Times. The center was created with $17 million in funding from private donors and a foundation. Some scientists have been exploring the potential of psychedelics and other recreational drugs for psychiatric problems since the early 2000s.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Team Coordination, Data Sharing Help Prioritize Value in Cardio-Renal-Metabolic Care
September 12th 2025Cardiologists, nephrologists, and payers met in Scottsdale, Arizona, on August 26, 2025, to share insights on how team members can work together, empowered by data, to achieve value-based management of cardio-renal-metabolic syndrome.
Read More